ニュース

Pharmabiz19 時間
US FDA approves Nuvation Bio’s taletrectinib for treatment of advanced ROS1-positive non ...
US FDA approves Nuvation Bio’s taletrectinib for treatment of advanced ROS1-positive non-small cell lung cancer: New York Saturday, June 14, 2025, 14:00 Hrs [IST] Nuvation Bio I ...